Sponsor Pipeline

Yue He, MD Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
0
Recruiting
1
Phase 3
1
Disease Areas
Active Trials by Phase
Phase 3
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07432087 Camrelizumab Combined With EGFR Monoclonal Antibody or Chemotherapy for Perioperative… Head and Neck Squamous Cell Carcinoma Not Yet Recruiting
Disease Areas
Head & Neck Cancer (1)
Get alerts when Yue He, MD's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free